This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2011 Jan;35(1):22-3.

doi: 10.1016/j.leukres.2010.07.033. Epub 2010 Aug 19.

Treatment of anemia with erythroid stimulating agents in myelodysplastic syndromes

Matteo G Della Porta

PMID: 20727588
DOI: 10.1016/j.leukres.2010.07.033

Editorial

Treatment of anemia with erythroid stimulating agents in myelodysplastic syndromes

Matteo G Della Porta. Leuk Res. 2011 Jan.

. 2011 Jan;35(1):22-3.

doi: 10.1016/j.leukres.2010.07.033. Epub 2010 Aug 19.

Author

Matteo G Della Porta

PMID: 20727588
DOI: 10.1016/j.leukres.2010.07.033

No abstract available

PubMed Disclaimer

Comment on

Early introduction of ESA in low risk MDS patients may delay the need for RBC transfusion: a retrospective analysis on 112 patients.
Park S, Kelaidi C, Sapena R, Vassilieff D, Beyne-Rauzy O, Coiteux V, Vey N, Ravoet C, Cheze S, Rose C, Legros L, Stamatoullas A, Escoffre-Barbe M, Guerci A, Chaury MP, Fenaux P, Dreyfus F. Park S, et al. Leuk Res. 2010 Nov;34(11):1430-6. doi: 10.1016/j.leukres.2010.05.030. Epub 2010 Jun 26. Leuk Res. 2010. PMID: 20580086

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information